Drug class
First-generation piperazine antihistamine; H1 receptor antagonist
Mechanism of action
Competitively antagonises histamine H1 receptors and has anticholinergic activity, reducing allergic symptoms and vestibular-mediated nausea.
General use cases
- Symptomatic treatment of allergic rhinitis, pruritus and urticaria in countries where chlorcyclizine products are authorised
- Prevention or treatment of motion sickness and associated nausea in selected formulations; current availability and indications vary by jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
